相关实验视频

Updated: May 8, 2026

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

贝纳米颗粒-奇托桑复合物的制备稳定了皮克林乳液凝及其在β-胡卜素输送中的应用

Yacheng Hao¹, Sai Li², Xiao Guo¹

¹Key Laboratory for Deep Processing of Major Grain and Oil (The Chinese Ministry of Education), College of Food Science and Engineering, Wuhan Polytechnic University, Wuhan, 430023, PR China; Hubei Key Laboratory for Processing and Transformation of Agricultural Products, Wuhan Polytechnic University, Wuhan 430023, PR China; National Engineering Research Center of Grain Storage and Logistics, Wuhan Polytechnic University, Wuhan 430023, PR China.

International journal of biological macromolecules

|October 16, 2024

概括

贝纳米颗粒和奇托复合物产生稳定的β-胡卜素输送凝. 这些新型乳液凝增强了β-胡卜素的生物可用性,用于改善食品应用.

科学领域:

食品科学食品科学食品科学
材料科学材料科学材料科学
生物技术是生物技术.

背景情况:

贝纳米粒子 (SNPs) 显示出作为输送载体的潜力,但具有较差的乳化特性.
开发稳定的皮克林乳液凝对于有效的输送系统至关重要.
素 (CS) 可以与SNP结合使用,以提高其功能.

研究的目的:

使用糖纳米粒子 (SNPs) 和酸盐 (CS) 复合物制造稳定的乳液凝.
开发一种用于β-胡卜素的新型输送系统.
研究SNP/CS复合体对质和结构性质的影响.

主要方法:

通过键和静电相互作用制造SNP/CS复合体.
优化SNP/CS比率,以达到约90°的接触角.
乳液凝的质性质和结构完整性的表征.

主要成果:

SNP/CS复合物作为双重乳化剂和凝剂.
在贝塔胡卜素封装后,凝强度保持稳定.
最佳的SNP/CS比率 (1/0.25) 产生了最高的β-胡卜素生物可访问性 (80.4%).

结论:

这些SNP/CS复合物有效地稳定了乳液凝.
开发的系统增强了β-胡卜素的生物可用性.
这项技术扩大了在食品工业中基于贝的乳液凝的应用.

关键词:

可以进行3D打印,3D打印.生物可访问性生物可访问性基托桑是一种酸盐.乳液凝是一种乳液凝.贝的纳米粒子.

更多相关视频

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles

Published on: January 22, 2015

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

相关概念视频

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...